|
|
 | | | |
- close
- close
- close
- close
Radient Pharmaceuticals (RPC) |
Benzinga
Jan 4
Comment
Radient Pharmaceuticals Corporation (RXPC) announced Tuesday that its Board of Directors has authorized the implementation of a 1:25 reverse split of the Company's outstanding common shares, which will be completed on or before January 15, 2012...
Phil’s Stock World
Jan 3
Comment
Courtesy of Benzinga. Radient Pharmaceuticals Corporation (RXPC) announced Tuesday that its Board of Directors has authorized the implementation of a 1:25 reverse split of the Company's outstanding common shares, which will be...
Marketwire
Oct 24
Comment
TUSTIN, CA -- (Marketwire) -- 10/24/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has filed patent
Marketwire
Oct 20
Comment
TUSTIN, CA -- (Marketwire) -- 10/20/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced that the lawsuits filed
Marketwire
Oct 4
Comment
TUSTIN, CA -- (Marketwire) -- 10/04/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced the launch of a national
Marketwire
Aug 23
Comment
TUSTIN, CA -- (Marketwire) -- 08/23/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has sold and shipped its
Marketwire
Aug 22
Comment
TUSTIN, CA -- (Marketwire) -- 08/22/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced the appointment of biotech
Marketwire
Aug 19
Comment
TUSTIN, CA -- (Marketwire) -- 08/19/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced the results from its annual
Marketwire
Aug 11
Comment
TUSTIN, CA -- (Marketwire) -- 08/11/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has signed a lab partner
Marketwire
Aug 4
Comment
TUSTIN, CA -- (Marketwire) -- 08/04/11 -- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC) (PINKSHEETS: RXPC), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has entered into an
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
